Back

Spatial Landscape of Pregnancy-Associated Triple Negative Breast Cancer and Mammary Gland Involution

Veraksa, D.; Mukund, K.; Frankhouser, D.; Yang, L.; Tomsic, J.; Pillai, R.; Venkatasubramani, J.; Schmolze, D.; Wu, X.-C.; LeBlanc, M.-A.; Miele, L.; Ochoa, A.; Seewaldt, V.; Subramaniam, S.

2026-03-12 cancer biology
10.64898/2026.03.09.710650 bioRxiv
Show abstract

Pregnancy-associated triple negative breast cancer (PA-TNBC) is one of the highest-risk breast cancers, marked by an aggressive phenotype that lacks targeted treatment options. Studies have shown that post-lactational mammary gland involution plays a role in this increased risk. To delineate the underlying mechanisms, our study characterized the transcriptional state of the epithelia and surrounding microenvironment in women with PA-TNBC, comparing those diagnosed pre-involution (PRE) and post-involution (POST, <3 years after delivery). Spatial transcriptomics using the GeoMx Digital Spatial Profiler was performed on treatment-naive PA-TNBC tissues from 33 women (10 PRE, 23 POST). Regions of interest were segmented with pan-cytokeratin staining. We found that the most prominent transcriptional differences between PRE and POST epithelia occurred in the adjacent non-invasive regions and during the transition into invasive TNBC. POST non-invasive epithelia uniquely showed inflammatory and developmental pathway activation, while the transition into TNBC involved increased chromatin remodeling and cell migration pathways. Further, the tumor microenvironment (TME) in POST showed the highest proportion of immune cells and the highest prevalence of tumor- and immune exhaustion-associated cell states. Finally, a pseudotime analysis of POST transcriptional dynamics found that women diagnosed 1-2 years after delivery exhibited the strongest evidence for inflammatory signaling across the tissue. Our results highlight biological mechanisms distinguishing PRE and POST PA-TNBC across tissue regions and cell types. We emphasize the importance of early detection of malignant molecular signatures in morphologically normal epithelium in post-involution women and suggest that targeting the TME may improve treatment efficacy in post-involution PA-TNBC.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Breast Cancer Research
32 papers in training set
Top 0.1%
22.2%
2
Cancers
200 papers in training set
Top 0.3%
12.3%
3
Scientific Reports
3102 papers in training set
Top 15%
6.7%
4
Cancer Research
116 papers in training set
Top 0.9%
3.5%
5
Cell Communication and Signaling
35 papers in training set
Top 0.1%
3.5%
6
PLOS ONE
4510 papers in training set
Top 43%
3.0%
50% of probability mass above
7
Frontiers in Oncology
95 papers in training set
Top 1%
2.8%
8
International Journal of Cancer
42 papers in training set
Top 0.4%
2.8%
9
BMC Cancer
52 papers in training set
Top 1%
2.0%
10
Cell Reports Medicine
140 papers in training set
Top 3%
2.0%
11
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 4%
1.7%
12
eLife
5422 papers in training set
Top 43%
1.7%
13
npj Breast Cancer
18 papers in training set
Top 0.1%
1.6%
14
Cell Reports
1338 papers in training set
Top 25%
1.6%
15
Nature Communications
4913 papers in training set
Top 54%
1.5%
16
PLOS Computational Biology
1633 papers in training set
Top 18%
1.5%
17
iScience
1063 papers in training set
Top 18%
1.5%
18
Genome Medicine
154 papers in training set
Top 6%
1.2%
19
Disease Models & Mechanisms
119 papers in training set
Top 2%
1.2%
20
Cell Death & Disease
126 papers in training set
Top 2%
0.9%
21
Cells
232 papers in training set
Top 5%
0.9%
22
Molecular Oncology
50 papers in training set
Top 0.8%
0.9%
23
Advanced Science
249 papers in training set
Top 18%
0.8%
24
eBioMedicine
130 papers in training set
Top 4%
0.8%
25
Communications Biology
886 papers in training set
Top 22%
0.8%
26
JNCI Cancer Spectrum
10 papers in training set
Top 0.5%
0.8%
27
Oncogene
76 papers in training set
Top 2%
0.7%
28
Clinical Epigenetics
53 papers in training set
Top 1%
0.7%
29
OncoImmunology
22 papers in training set
Top 0.4%
0.7%
30
Molecular Cancer Research
42 papers in training set
Top 0.8%
0.7%